Your browser doesn't support javascript.
loading
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.
Zhu, Zhoujie; Shi, Jiayi; Li, Long; Wang, Jinling; Zhao, Yufen; Ma, Huabin.
Afiliação
  • Zhu Z; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
  • Shi J; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
  • Li L; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
  • Wang J; Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo, China.
  • Zhao Y; School of Medicine, Xiamen University, Xiamen, China.
  • Ma H; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
Front Immunol ; 13: 870216, 2022.
Article em En | MEDLINE | ID: mdl-35655782
Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article